| ²é¿´: 1686 | »Ø¸´: 5 | ||
Ñî¶þ¶þºÃѧϰгæ (³õÈëÎÄ̳)
|
[ÇóÖú]
ÃÀ¹úÒ©µä»òÅ·ÖÞÒ©µä¹ØÓÚɽݹÝмÏûÐýɽݹÝмÔÁÏÒ©¡¢ÖƼÁ£©µÄ±ê×¼£¬Ð»Ð»¡£
|
|
|
¼±Çó£¬ÃÀ¹úÒ©µä»òÅ·ÖÞÒ©µä¹ØÓÚɽݹÝмÏûÐýɽݹÝмÔÁÏÒ©¡¢ÖƼÁ£©µÄ±ê×¼¡£×ÜÊÇÕÒ²»µ½¡£ÏëÖªµÀÊDz»ÊÇûÓС£Ð»Ð»¡£ ÒÑÓãºAnisodamine£¬raceanisodamine ¡£Ëѹý¡£ |
» ²ÂÄãϲ»¶
²ÄÁÏÓ뻯¹¤300Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
µ÷¼Á
ÒѾÓÐ10È˻ظ´
²ÄÁÏÀà284µ÷¼Á
ÒѾÓÐ35È˻ظ´
070300»¯Ñ§ Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
»¯¹¤Çóµ÷¼Á£¡
ÒѾÓÐ33È˻ظ´
²ÄÁÏ»¯¹¤×Ü·Ö334Çóµ÷¼Á
ÒѾÓÐ17È˻ظ´
071000ÉúÎïѧµ÷¼ÁÇóÖú
ÒѾÓÐ10È˻ظ´
269Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸211 0703»¯Ñ§ 346·ÖÇóµ÷¼Á
ÒѾÓÐ19È˻ظ´
²©Ê¿×Ô¼ö
ÒѾÓÐ4È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
×ö¹Ì»¯DSC£¬¹Ì»¯ÆðʼζÈÊÇÒÔonsetΪ׼£¬»¹ÊÇÒÔ»ùÏßÇÐÏß¿ªÊ¼ËãÆð£¿Ð»Ð»
ÒѾÓÐ6È˻ظ´
Ê®Íò»ð¼±£¡£¡£¡£¡£¡ÇóÖú£¬ лл
ÒѾÓÐ8È˻ظ´
Ͷ¸å»ØÀ´£¬¾§Ìå½âÎö²¿·Ö²»»á»Ø´ð£¬ÇóÖú¸ßÊÖ£¬±ÏÒµ¼±£¬Ð»Ð»
ÒѾÓÐ7È˻ظ´
ÂÛÎÄ·ÒëÇóÖú£¬´ó¼Ò°ï°ï棬лл
ÒѾÓÐ1È˻ظ´
ѹµçÌÕ´ÉÓÐ×öÁ¦Ñ§ÐÔÄܲâÊÔµÄÂð£¿Ð»Ð»
ÒѾÓÐ16È˻ظ´
Çó¸ßÊÖÐÞÕýÓ¢ÓïÕªÒª¡£ лл£¡
ÒѾÓÐ3È˻ظ´
¹ØÓÚÏÞÏÇë°ï棬лл
ÒѾÓÐ19È˻ظ´
ÇëÎÊÔÚÄÄ¿ÉÒÔ²éѯij¸ö±±¾©µÄµ¥Î»ÊÇ·ñ¾ßÓжÀÁ¢ÈËÊÂȨ£¿Ð»Ð»¡£
ÒѾÓÐ30È˻ظ´
¹ØÓÚ½Á°è·´Ó¦Æ÷µÄÄ£Ä⣬лл
ÒѾÓÐ8È˻ظ´
¹ØÓÚHF·½·¨ºÍDFT·½·¨ÖйìµÀÄÜÁ¿µÄ²î±ð
ÒѾÓÐ11È˻ظ´
ÇóÖú¹ã´ó³æÓÑ£º ¹ØÓÚÓÃÁ÷¶¯ÏàÏ¡ÊÍ±êÆ·µÄÎÊÌâ лл£¡£¡£¡
ÒѾÓÐ9È˻ظ´
¡¾ÇóÖú¡¿¡¾¸ß·ÖÐüÉÍ¡¿ÃÀ¹úÒ©µä Å·ÖÞÒ©µä ÈÕ±¾Ò©¾Ö·½µÄ ¸½Â¼Ä¿Â¼Ò³
ÒѾÓÐ3È˻ظ´
¡¾ÇóÖú¡¿Å·ÖÞÒ©µäºÍÃÀ¹úÒ©µä¶ÔÒøÐÓÒ¶ÌáÈ¡ÎïµÄ±ê×¼
ÒѾÓÐ3È˻ظ´
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï
karl2100: ½ð±Ò+1, лл£¡ 2012-05-06 00:53:38
Ñî¶þ¶þºÃѧϰ: »ØÌûÖö¥ 2012-05-06 15:00:55
Ñî¶þ¶þºÃѧϰ: ½ð±Ò+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, лл 2012-05-06 15:01:32
karl2100: ½ð±Ò+1, лл£¡ 2012-05-06 00:53:38
Ñî¶þ¶þºÃѧϰ: »ØÌûÖö¥ 2012-05-06 15:00:55
Ñî¶þ¶þºÃѧϰ: ½ð±Ò+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, лл 2012-05-06 15:01:32
|
Âí¶¡´ú¶û¿ÉÒԲ鵽£¬ Ã÷È·Ö»ÓÐÖйúÒ©µäÓÐÓ¦Ó㺠Anisodamine 6-Hydroxy-hyoscyamine. C17H23NO4 = 305.4. CAS ¡ª 55869-99-3. Pharmacopoeias. Chin. has a monograph for Raceanisodamine and Anisodamine Hydrobromide. Profile Anisodamine is an alkaloid isolated from Scopolia tangutica (Anisodus tanguticus), a plant used as a traditional medicine in China. It is related to atropine and hyoscyamine and has similar antimuscarinic properties (p.1221). Anisodamine is given orally for its spasmolytic actions in the treatment of gastrointestinal spasm. It has also been tried in circulatory disorders, septic shock, and organophosphorus poisoning. ◊ References. 1. Poupko JM, et al. The pharmacological properties of anisodamine. J Appl Toxicol 2007; 27: 116¨C21. 2. Fu XH, et al. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute |
5Â¥2012-05-05 22:11:16
ÅÝÅÝ-211
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
- PhEPI: 1
- Ó¦Öú: 101 (¸ßÖÐÉú)
- ½ð±Ò: 12710.8
- ºì»¨: 8
- ɳ·¢: 35
- Ìû×Ó: 7496
- ÔÚÏß: 1516Сʱ
- ³æºÅ: 293006
- ×¢²á: 2006-11-04
- ÐÔ±ð: GG
- רҵ: Ò©¼Áѧ

2Â¥2012-05-05 16:54:22
Ñî¶þ¶þºÃѧϰ
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 170
- Ìû×Ó: 30
- ÔÚÏß: 11Сʱ
- ³æºÅ: 1778358
- ×¢²á: 2012-04-25
- ÐÔ±ð: MM
- רҵ: ÉúÎï¼¼ÊõÒ©Îï
3Â¥2012-05-05 19:41:49
4Â¥2012-05-05 22:09:50
Ñî¶þ¶þºÃѧϰ
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 170
- Ìû×Ó: 30
- ÔÚÏß: 11Сʱ
- ³æºÅ: 1778358
- ×¢²á: 2012-04-25
- ÐÔ±ð: MM
- רҵ: ÉúÎï¼¼ÊõÒ©Îï
6Â¥2012-05-06 15:01:12













»Ø¸´´ËÂ¥